What's breaking now, across thousands of outlets.
A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to standard treatment.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
People who felt more scared inside a haunted house, and held hands or touched their companions, were more likely to say the experience brought them closer.
Cal's recent diagnosis has Kayce reflecting on Monica's own battle with cancer on Sunday's Marshals. Watch an exclusive sneak peek.
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
The departure comes amid turmoil in Kennedy's Make America Healthy Again movement.
Medicare negotiated drug prices for 15 drugs, including Ozempic, Wegovy and Trelegy Ellipta, take effect January 1, 2027, with cuts ranging from 38% to 85%
A combination of the shot and the immunotherapy Keytruda cut the risk of relapse or death by 42% in a landmark melanoma study that met Wall Street expectations but triggered a “sell-the-news…
